Federal Resources and Updates
STD Treatment Options -CDC Dear Colleague Letter, harm reduction STD treatment options for use during COVID, 4/6/2020
Dear Colleague: CDC Grantee Guidance from Dr. Jonathan Mermin, CDC – 3/25/20, Guidance on additional flexibility CDC has made available to its grantees
CDC Pushes Back Ending the HIV Epidemic Application Deadlines — CDC’s Division of HIV/AIDS Prevention has made the following changes to help reduce any burdens associated with the development and submission of your PS20-2010 applications: Components A and C Applications: The new application deadline for Components A&C is May 1, 2020, 11:59 p.m. Eastern Standard Time. The new award start date will be August 1, 2020; Component B Applications: Jurisdictions eligible for Component B funding are now only required to express their intent to apply for Component B when submitting their core Component A application. No other documentation is needed at this time (i.e., work plan or budget). CDC will provide eligible jurisdictions with updated application guidance specific to Component B at a later date.
340B HRSA COVID-19 guidance – HRSA
Interim Guidance for COVID-19 and Persons with HIV – US Dept. of Health and Human Services
Communication Resources – CDC
RWHAP Recipient Update – HRSA’s HIV/AIDS Bureau (HRSA HAB) is extending the RWHAP Services Report (RSR) reporting deadline by 30 days to Thursday, April 30, 2020. The RSR is open and recipients can submit as early as possible; however, data will be accepted through April 30, 2020.